Innovative Nobu Trading Meets With Buyers from Large and Small Retail Chains in the U.S.
11 oct. 2021 16h09 HE
|
NOBU TRADING LTD
PALM BEACH, FL, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Nobu Trading moved closer to entering the U.S. market when it met with buyers from large and small retail chains in the United State attending the...
Nobu Trading’s Innovative Health Products for Babies, Kids, and Adults to Debut at ECRM’s ‘Vitamin, Weight Management & Sports Nutrition Program’
09 sept. 2021 13h21 HE
|
NOBU TRADING LTD
PALM BEACH, FL, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Nobu Trading’s popular healthcare product lines for babies, children, and adults will debut in America this month at ECRM’s “Vitamin, Weight...
Nobu Trading Plans U.S. Launch of its Innovative Health Products for Babies, Kids, and Adults
02 août 2021 12h17 HE
|
NOBU TRADING LTD
PALM BEACH, FL, Aug. 02, 2021 (GLOBE NEWSWIRE) -- This week, London-based Nobu Trading announced plans to export its popular healthcare product lines for babies, children, and adults to America. ...
Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2
14 juil. 2021 09h00 HE
|
Auris Medical AG
Bentrio™ formulation well tolerated in vitro on human nasal epitheliumUp to 99% reduction of SARS-CoV-2 viral titer with prophylactic treatment vs. controlsViral titer reduced 12- or 14-fold vs....
Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany
28 juin 2021 08h30 HE
|
Auris Medical AG
Hamilton, Bermuda, June 28, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection,...
Inhalation & Nasal Spray Generic Drugs Market at CAGR of 8.29% by 2031: Visiongain Research Inc.
17 juin 2021 12h30 HE
|
Visiongain Ltd
Visiongain has published a new report on Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031. Profiles of Inhalation & Nasal Spray Generic Drugs and Forecasts By Drug Class...
Auris Medical Starts Preparations for Covid-19 Trial with Bentrio in India
01 juin 2021 08h30 HE
|
Auris Medical AG
Hamilton, Bermuda, June 1, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology,...
Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301 and Details Plans for Market Launch
13 avr. 2021 07h45 HE
|
Auris Medical AG
Clinical evaluation of AM-301 nasal spray in allergic rhinitis meets primary endpoint Extended protection achieved over several hoursPreliminary preclinical data suggest therapeutic utility post...
Auris Medical Announces Initiation of Clinical Investigation of AM-301 in Allergic Rhinitis
29 janv. 2021 08h30 HE
|
Auris Medical AG
Hamilton, Bermuda, January 29, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection
01 déc. 2020 09h00 HE
|
Auris Medical AG
Up to 99.4% reduction of viral titer in human epithelial cell culture (p<0.001)Results suggest potential for AM-301 nasal spray to mitigate risk of Sars-CoV-2 infection Hamilton, Bermuda, December...